Kenneth Simon Email

Senior Director, Biology . Revitope

Current Roles

Employees:
11
Revenue:
$1.7M
About
Revitope is an early stage biotechnology company focused on developing the next-generation of T cell redirecting biologics. Immune-based therapies are redefining how cancer is treated as clinical studies demonstrate unprecedented deep and durable responses in multiple cancers. In particular redirecting T cells to tumors is a successful strategy for immunotherapy of liquid tumors. However, unleashing a potent immune response that is entirely focused on the tumor continues to be elusive. Revitope is developing a new class of biologic prodrugs we call Programmable Antibody Circuits or PACs that are engineered to focus immune activation to the cancer cell surface while expanding the antigenic targeting space.
Revitope Address
700 Main St
Cambridge, MA
United States
Revitope Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.